Skip to content

Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue

Non-Invasive, Real-time Technology for Diagnosis of Cervical Tissue

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00250055
Enrollment
100
Registered
2005-11-07
Start date
2004-04-30
Completion date
2010-01-31
Last updated
2024-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Cervix

Keywords

NIH, Non-Invasive diagnosis of cervical tissue, Los Alamos/NIH

Brief summary

In general, to determine the sensitivity of light transport to tissue from morphological features of clinical significance. Determine how specific structural features contribute to light scattering. Investigate light scattering differences in tumorigenic and nontumorigenic cells. Develop and implement quantitative and sensitive methods for measuring morphological properties. Clinical measurements.

Detailed description

Patients undergoing a colposcopy will also have spectroscopy measurements taken and an extra biopsy of suspicious tissue.

Interventions

PROCEDUREColposcopy, Spectroscopy, and Biopsy

During the colposcopy or LEEP (Loop Electrical Excision Procedure) procedure, or during pelvic exams before surgery after the doctor applies 3% acetic acid to the cervix, the doctor then positions the colposcope to take pictures of the patient's cervix. Digital pictures are taken of the patient's cervix under white light using a colposcopy imaging system. These pictures are annotated by the doctor during the appointment to mark the spectroscopy sites.

Sponsors

University of New Mexico
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with abnormal Pap smears who are referred for colposcopy.

Exclusion criteria

include: * Anyone of the male sex since this study focuses on cervical cell abnormalities * Any woman who has had a hysterectomy, LEEP, or chemotherapy.

Design outcomes

Primary

MeasureTime frame
The objective of this study is to determine whether non-invasive measurements of light transport through tissue can identify pre-cancerous and cancerous conditions.6 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026